Skip to main content
. 2015 Aug 6;309(8):G648–G661. doi: 10.1152/ajpgi.00170.2015

Table 1.

Summary of published studies documenting obesity or hepatic lipid phenotypes in L-Fabp−/− mouse lines

Authors Ref. No. KO Line Sex Age Diet Background Control KO Phenotype
Studies showing increased obesity or hepatic lipid
Martin et al.,J Biol Chem, 2003 22 Fabp1tm1Bin F 13–15 mo Chow Mixed Littermate Increased liver chol, CE, PL
Martin et al., Biochemistry, 2003 23 Fabp1tm1Bin F 13–15 mo Chow Mixed Littermate Increased liver CE, PL; decreased liver TG
Martin et al., Am J Physiol Gastrointest Liver Physiol, 2006 18 Fabp1tm1Bin F 7–12 wk 1.25% Chol/control Mixed Littermate Increased BW on control and chol. Increased liver chol
Martin et al., Mol Cell Biochem, 2009 21 Fabp1tm1Bin M 3–18 mo Chow N6 to C57BL/6? C57BL/6? Increased BW by 9 mo; liver TG decreased at 3 mo, not 18 mo
Martin et al., J Nutr, 2008 19 Fabp1tm1Bin F 3–18 mo Chow N6/C57BL/6? C57BL/6? Increased BW by 9 mo; liver TG decreased at 3 mo, not 18 mo
Martin et al., Am J Physiol Gastrointest Liver Physiol, 2009 17 Fabp1tm1Bin Both >8 mo Chow From N2 to N10 to C57BL/6NCr Littermate Increased liver chol in F; Decreased liver TG in M
Atshaves et al., Lipids, 2010 3 Fabp1tm1Bin Both 7–20 wk Control, HFD, pair fed N6 C57Bl/6NCr C57BL/6NCr Increased BW in HFD-fed F; no Δ in M. No Δ in liver TG
McIntosh et al., Lipids, 2013 24 Fabp1tm1Bin F 8–20 wk Control, HFD N11 C57Bl/6NCr C57BL/6NCr Increased BW on HFD, not control
Gajda et al., J Biol Chem, 2013 12 Fabp1tm1Bin M 8–20 wk High SF, UF diets N6 C57BL/6J C57BL/6J Increased BW and weight gain on both HFD
Studies showing decreased/unchanged obesity or hepatic lipid
Newberry et al., J Biol Chem, 2003 29 Fabp1tm1Ddsn M 2–4 mo Chow, fasted Mixed Littermate Decreased liver TG after fasting
Atshaves et al., J Biol Chem, 2004 4 Fabp1tm1Bin M 2–4 mo Chow, AIN76A Mixed Littermate Decreased liver TG, FA, total lipid
Atshaves et al., Am J Physiol Cell Physiol, 2005 2 Fabp1tm1Bin Both 2 mo Chow, phytanic acid Mixed Littermate Decreased liver TG in M
Martin et al., Biochem J, 2005 20 Fabp1tm1Bin M 7–12 wk 1.25% Chol/control Mixed Littermate No Δ in BW; liver TG decreased on control diet
Newberry et al., Hepatology, 2006 30 Fabp1tm1Ddsn F 12–30 wk Western HFD N5 to C57BL/6J C57BL/6J Decreased BW on HFD. Decreased liver TG
Newberry et al., Am J Physiol Gastrointest Liver Physiol, 2008 28 Fabp1tm1Ddsn F 2–8 mo 1.25% Chol, SF, and PUFA N8 to C57BL/6J C57BL/6J Decreased obesity/liver TG on SF and chol, but not PUFA diet
Newberry et al., Mol Cell Biochem, 2009 27 Fabp1tm1Ddsn F 10–24 wk High chol, SF, and Western N7 to C57BL/6J C57BL/6J Reduced weight gain on HF and chol diets
Lagakos et al., Am J Physiol Gastrointest Liver Physiol, 2011 15 Fabp1tm1Bin M 0–5 mo Chow N6 C57BL/6J Littermate No difference in BW at 5 mo
Newberry et al., J Lipid Res, 2012 26 Fabp1tm1Ddsn F 3–13 mo Chow N7 to C57BL/6J C57BL/6J Reduced BW by 5 mo; liver TG lower at 3 and 13 mo
Chen et al., Hepatology, 2013 7 Fabp1tm1Ddsn F 8–20 HF, high fructose N8–9 to C57BL/6J C57BL/6J Reduced hepatic TG

KO, knockout; F, female; M, male; HFD, high-fat diet (fat source not indicated); SF, high-saturated fat diet; UF, unsaturated fat diet; chol, cholesterol; CE, cholesterol ester; PL, phospholipid; TG, triglyceride; BW, body weight; Δ, change; chow, rodent chow diet; FA, fatty acid; PUFA, high polyunsaturated fat diet. “C57BL/6?” indicates that the specific substrain was not reported.